Systematic review of neoadjuvant therapy by immune checkpoint inhibitors before radical cystectomy: where do we stand?
Author:
Publisher
Edizioni Minerva Medica
Subject
Urology,Nephrology
Link
https://www.minervamedica.it/pdf.php?cod=R19Y2020N06A0663
Reference48 articles.
1. Epidemiology and unmet needs of bladder cancer in Italy: a critical review
2. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018
3. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250]
4. Bladder-sparing treatment in MIBC: where do we stand?
5. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments;Clinical Medicine Insights: Oncology;2024-01
2. Bladder-sparing treatment for muscle-invasive bladder carcinoma using immune checkpoint inhibitors;Critical Reviews in Oncology/Hematology;2023-11
3. Comment on "Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis" on behalf of the Young Academic Urologists - Urothelial Cancer Working Group;Minerva Urology and Nephrology;2023-01
4. Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis;Minerva Urology and Nephrology;2022-09
5. A gender-related dichotomy in bladder cancer;Minerva Urology and Nephrology;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3